These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8764356)

  • 1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
    Bellissant E; Denolle T; Sinnassamy P; Bichet DG; Giudicelli JF; Lecoz F; Gandon JM; Allain H
    J Pharmacol Exp Ther; 1996 Jul; 278(1):232-42. PubMed ID: 8764356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis.
    Moreau R; Cailmail S; Hamon G; Lebrec D
    J Gastroenterol Hepatol; 1996 Sep; 11(9):857-63. PubMed ID: 8889966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis.
    Gadano A; Moreau R; Pessione F; Trombino C; Giuily N; Sinnassamy P; Valla D; Lebrec D
    J Hepatol; 2000 Jan; 32(1):38-42. PubMed ID: 10673065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niravoline, a selective kappa-opioid receptor agonist effectively reduces elevated intracranial pressure.
    Nagao S; Bemana I; Kuratani H; Takahashi E; Nakamura T
    Exp Brain Res; 2000 Feb; 130(3):338-44. PubMed ID: 10706433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of niravoline (RU 51599), a selective kappa-opioid receptor agonist on intracranial pressure in gradually expanding extradural mass lesion.
    Bemana I; Nagao S
    J Neurotrauma; 1998 Feb; 15(2):117-24. PubMed ID: 9512087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke.
    Guéniau C; Oberlander C
    J Pharmacol Exp Ther; 1997 Jul; 282(1):1-6. PubMed ID: 9223533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.
    Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers.
    Floyd BN; Camilleri M; Busciglio I; Sweetser S; Burton D; Wong GY; Kell S; Khanna S; Hwang S; Zinsmeister AR
    Neurogastroenterol Motil; 2009 Mar; 21(3):281-90. PubMed ID: 18823290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic actions in man of a selective kappa opioid agonist: U-62,066E.
    Peters GR; Ward NJ; Antal EG; Lai PY; deMaar EW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):128-31. PubMed ID: 3027300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man.
    Ur E; Wright DM; Bouloux PM; Grossman A
    Br J Pharmacol; 1997 Mar; 120(5):781-4. PubMed ID: 9138682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
    Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
    Ohnishi A; Mihara M; Yasuda S; Tomono Y; Hasegawa J; Tanaka T
    J Pharmacol Exp Ther; 1994 Jul; 270(1):342-7. PubMed ID: 7913498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of niravoline, an arginine vasopressin inhibitor, on tumour-origin brain oedema.
    Takahashi H; Hamada H; Teramoto A
    Acta Neurochir Suppl; 2000; 76():323-7. PubMed ID: 11450035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.